A Comparison of Treatment Effect Sizes in Matched Phase 2 and Phase 3 Trials of Advanced Therapeutics in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.

Hanzel J, Solitano V, Zou L, Zou GY, Peyrin-Biroulet L, Danese S, Singh S, Ma C, Wils P, Jairath V

Open source

DOI
10.14309/ctg.0000000000000629
Published
2023 Nov 1
Container
Clinical and translational gastroenterology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.14309/ctg.0000000000000629,
  title = {A Comparison of Treatment Effect Sizes in Matched Phase 2 and Phase 3 Trials of Advanced Therapeutics in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.},
  author = {Hanzel J and Solitano V and Zou L and Zou GY and Peyrin-Biroulet L and Danese S and Singh S and Ma C and Wils P and Jairath V},
  year = {2023},
  journal = {Clinical and translational gastroenterology},
  doi = {10.14309/ctg.0000000000000629},
  url = {https://doi.org/10.14309/ctg.0000000000000629}
}

RIS

TY  - JOUR
TI  - A Comparison of Treatment Effect Sizes in Matched Phase 2 and Phase 3 Trials of Advanced Therapeutics in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
AU  - Hanzel J
AU  - Solitano V
AU  - Zou L
AU  - Zou GY
AU  - Peyrin-Biroulet L
AU  - Danese S
AU  - Singh S
AU  - Ma C
AU  - Wils P
AU  - Jairath V
PY  - 2023
JO  - Clinical and translational gastroenterology
DO  - 10.14309/ctg.0000000000000629
UR  - https://doi.org/10.14309/ctg.0000000000000629
ER  - 

APA

J, H., V, S., L, Z., GY, Z., L, P., S, D., S, S., C, M., P, W., & V, J. (2023). A Comparison of Treatment Effect Sizes in Matched Phase 2 and Phase 3 Trials of Advanced Therapeutics in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.. Clinical and translational gastroenterology. https://doi.org/10.14309/ctg.0000000000000629

Source records